Objective: This study is aimed at prenatal diagnosis of mosaic trisomy 12 and reviewing the literature. Materials and Methods: A 34-year-old woman underwent amniocentesis at 17 weeks of gestation because of advanced maternal age. Cytogenetic analysis of cultured amniocytes revealed a karyotype of 47,XX,þ12[9]/46,XX [14] . She was referred to the hospital for genetic counseling. Repeated amniocentesis was performed at 22 weeks of gestation. Array comparative genomic hybridization (aCGH), interphase fluorescence in situ hybridization (FISH) and quantitative fluorescent polymerase chain reaction (QF-PCR) were applied on uncultured amniocytes, and conventional cytogenetic analysis was applied on cultured amniocytes. Results: The aCGH analysis on uncultured amniocytes revealed a small genomic gain in chromosome 12. Interphase FISH analysis on uncultured amniocytes using a 12q11-q12-specific probe of RP11-496H24 (green spectrum) showed three green signals in 17.8% (8/45 cells) of uncultured amniocytes. QF-PCR analysis on uncultured amniocytes using chromosome 12-specific microsatellite markers excluded uniparental disomy 12. Cytogenetic analysis of cultured amniocytes revealed a karyotype of 47,XX,þ12[5]/46,XX [25] . The parents decided to continue the pregnancy. A healthy 3270 g female baby was delivered at 39 weeks of gestation, with no phenotypic abnormalities. Cytogenetic analysis of the cord blood revealed a karyotype of 46,XX in 40/40 cultured lymphocytes. The neonate was normal in growth and psychomotor development at 6 months of age. Interphase FISH analysis on uncultured urinary cells revealed 5% (1/20 cells) mosaicism for trisomy 12. Conclusion: Prenatal diagnosis of mosaic trisomy 12 at amniocentesis should alert a clinically significant aneuploidy. Interphase FISH and aCGH on uncultured amniocytes are useful for rapid confirmation of low-level trisomy 12 mosaicism at repeated amniocentesis.
Introduction
Mosaic trisomy 12 is one of the commonly described mosaicisms at amniocentesis that has been well described in the literature [1e20] . Postnatally diagnosed trisomy 12 mosaicism has a variable phenotype, and the reported phenotypic abnormalities include developmental delay, pigmentary dysplasia, congenital heart defects, microcephaly, facial asymmetry, prominent ears, hypotonia, hemihyperplasia, intestinal malrotation, retinopathy, and sensorineural hearing loss [11,21e28] . Herein, we present our experience of prenatal diagnosis of mosaic trisomy 12 by amniocentesis and a review of the literature.
Materials and methods
A 34-year-old, gravida 3, para 1, woman underwent amniocentesis at 17 weeks of gestation because of advanced maternal age. Cytogenetic analysis of cultured amniocytes revealed a karyotype of 47,XX,þ12 [9] /46,XX [14] . She was referred to the hospital for genetic counseling. The parental karyotypes were normal, and prenatal ultrasound findings were unremarkable. Repeated amniocentesis was performed at 22 weeks of gestation. Array comparative genomic hybridization (aCGH), interphase fluorescence in situ hybridization (FISH) and quantitative fluorescent polymerase chain reaction (QF-PCR) were applied on uncultured amniocytes, and conventional cytogenetic analysis was applied on cultured amniocytes.
Results
The aCGH analysis using CytoChip Oligo Array (BlueGnome, Cambridge, UK) on uncultured amniocytes revealed a small genomic gain in chromosome 12 ( Fig. 1) . Interphase FISH analysis on uncultured amniocytes using a 12q11-q12-specific probe of RP11-496H24 (green spectrum) showed three green signals in 17.8% (8/45 cells) and two green signals in 82.2% (37/45 cells) of uncultured amniocytes (Fig. 2) . QF-PCR analysis on uncultured amniocytes using chromosome 12-specific microsatellite markers revealed a 1:1 biparental diallelic pattern for chromosome 2 and thus excluded uniparental disomy (UPD) 12 (Fig. 3) . Cytogenetic analysis of cultured amniocytes revealed a karyotype of 47,XX,þ12 [5] / 46,XX [25] . Of 30 colonies of cultured amniocytes, five colonies (16.7%) had the karyotype of 47,XX,þ12 (Fig. 4) , whereas the other 25 colonies (83.3%) had the karyotype of 46,XX. The parents decided to continue the pregnancy. A healthy 3270 g female baby was delivered at 39 weeks of gestation, with no phenotypic abnormalities. Cytogenetic analysis of cord blood revealed a karyotype of 46,XX in 40/40 cultured lymphocytes. The neonate was normal in growth and psychomotor development at 6 months of age. Interphase FISH analysis on uncultured urinary cells at the age of 6 months, using 12q11-q12-specific probe of RP11-496H24 Fig. 2 . Interphase fluorescence in situ hybridization analysis on uncultured amniocytes using the a 12q11-q12-specific probe RP11-496H24 (green spectrum) shows: (A) three green signals in a trisomy 12 cell; (B) two green signals in a disomy 12 cell. 
Discussion
Molecular cytogenetic techniques, such as aCGH, interphase FISH and QF-PCR, on uncultured amniocytes for rapid positive confirmation of trisomy mosaicism have been well described [29e34] . The present case shows that in case of trisomy 12 at amniocentesis, interphase FISH on uncultured amniocytes is useful for rapid confirmation of low-level mosaicism, aCGH on uncultured amniocytes is useful for confirmation of the presence of about 20% mosaicism, and QF-PCR assay on uncultured amniocytes is useful for rapid exclusion of UPD. The present case also provides evidence for a correlation of low-level trisomy 12 mosaicism in uncultured amniocytes with a favorable fetal outcome. In the present case, the first amniocentesis revealed 39.1% (9/23 colonies) mosaicism for trisomy 12 in cultured amniocytes, and the second amniocentesis revealed 16.7% (5/30 colonies) mosaicism for trisomy 12 in cultured amniocytes and 17.8% (8/45 colonies) mosaicism for trisomy 12 in uncultured amniocytes detected by interphase FISH. Different amniocenteses have been reported to result in inconsistent trisomy 12 mosaicism levels in cultured amniocytes and make genetic counseling difficult [7, 9, 13, 20] . For examples, Frohlich and Falk [7] reported 7% versus 0%, Cartolano et al [9] reported 26.7% versus 0%, Spiro et al [13] reported 7.5% versus 48%, and Gentilin et al [20] reported 17.6% versus 62.5% mosaicism for trisomy 12 between two different amniocenteses. We think that interphase FISH on uncultured amniocytes in repeated amniocentesis is very practical for determining the real mosaicism level under such a circumstance.
To date, at least 32 cases of mosaic trisomy 12 detected by amniocentesis have been reported (Table 1) . Of these, at least nine cases (9/32 ¼ 28.1%) [3, 4, 11, 14, 16, 17, 19] were associated with prominent phenotypic abnormalities, suggesting that the malformation risk should be concerned in prenatal diagnosis of mosaic trisomy 12 by amniocentesis. In nine cases with an apparently abnormal outcome, the percentage of trisomic cells in cultured amniocytes varied from 4.3% to 61.9% (with 5 cases >34%). In 23 cases with a normal outcome, the percentage of trisomic cells in cultured amniocytes varied from 6.1% to 64.3% (with 3 cases > 34%). These findings indicate a correlation between a higher trisomy 12 mosaicism level and an abnormal fetal outcome. Table 1 shows that the male:female sex ratio for fetal mosaic trisomy 12 is 0.103 (3 males/29 females), indicating a female preponderance in fetal mosaic trisomy 12 and a natural selection against male mosaic trisomy 12 conceptuses. Table 1 also shows that mosaic trisomy 12 can prenatally be associated with elevated maternal serum afetoprotein [14] , elevated maternal serum human chorionic gonadotrophin [12] , abnormal maternal serum screening [12, 14] and abnormal ultrasound findings [2, 11, 12] . Table 1 additionally shows that the reported abnormal ultrasound findings associated with mosaic trisomy 12 at amniocentesis include polyhydramnios, intrauterine growth restriction, single umbilical artery, congenital heart defects, hydronephrosis and absence of stomach image.
Mosaic trisomy 12 detected postnatally has been described in nine cases (2 males/7 females) [11,21e28] . Schinzel [35] concluded that there is no clinical pattern due to trisomy 12 mosaicism. Richer et al [21] first reported a 31-year-old phenotypically normal infertile man with 7% mosaicism for trisomy 12 in 157 peripheral blood lymphocytes and Kartagener syndrome of situs inversus, chorionic sinusitis, bronchitis and immotile spermatozoa. Patil et al [22] reported a 36-year-old moderately mentally retarded female with a karyotype of 47,XX,þ12 [7] /46,XX [49] in peripheral blood, facial dysmorphisms, short stature, microcephaly, muscle stiffness, areflexia limited extension of joints, waddling gaits and scoliosis. English et al [23] reported a 7-year-old mentally normal girl with a karyotype of 47,XX,þ12 [6] /46,XX[50] in skin fibroblasts, short stature, scoliosis, pigmentary dysplasia and [17] in the skin fibroblasts from hyperpigmented and hypopigmented regions, facial dysmorphisms, developmental delay, microcephaly, unilateral sensorineural hearing loss, intestinal malrotation, hemihyperplasia, pigmentary dysplasia, retinopathy and a vascular ring. In summary, we present prenatal diagnosis and molecular cytogenetic analysis of mosaic trisomy 12 using uncultured and cultured amniocytes in a pregnancy with a favorable fetal outcome. We demonstrate the usefulness of analyses of uncultured amniocytes by interphase FISH and aCGH for rapid confirmation of low-level trisomy 12 mosaicism at amniocentesis, and by QF-PCR for rapid exclusion of UPD. 
